Alzheimer's A beta(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells
- PMID: 9288730
- DOI: 10.1038/nm0997-1021
Alzheimer's A beta(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells
Abstract
Alzheimer's disease (AD) is a neurodegenerative disorder involving the florid deposition of vascular and cerebral plaques composed chiefly of amyloid beta-peptide (A beta) derived from cleavage of the amyloid precursor protein (APP). Varying in length from 39 to 43 amino acids, A beta, particularly the longer A beta(42), is thought to play a significant role in AD pathogenesis. To better understand AD it is important to identify the subcellular organelles generating A beta. Studies using agents that disrupt endosomal/lysosomal function suggest that A beta is generated late in the secretory and endocytic pathways. However, much of what is known about A beta biosynthesis has been inferred by monitoring extracellular A beta levels since intracellular A beta is undetectable in most cell types. Consequently, the precise site or sites that generate A beta, or whether A beta(1-40) and A beta(1-42) are generated at the same point in the biosynthetic pathway, is not known. Using human NT2N neurons, we found that retention of APP in the endoplasmic reticulum/intermediate compartment (ER/IC) by three independent approaches eliminated production of intracellular A beta(1-40), but did not alter intracellular A beta(1-42) synthesis. These findings suggest that the ER/IC may be an important site for generating this highly amyloidogenic species of A beta.
Similar articles
-
A distinct ER/IC gamma-secretase competes with the proteasome for cleavage of APP.Biochemistry. 2000 Feb 1;39(4):810-7. doi: 10.1021/bi991728z. Biochemistry. 2000. PMID: 10651647
-
Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides.Nat Med. 1997 Sep;3(9):1016-20. doi: 10.1038/nm0997-1016. Nat Med. 1997. PMID: 9288729
-
Novel beta-secretase cleavage of beta-amyloid precursor protein in the endoplasmic reticulum/intermediate compartment of NT2N cells.J Cell Biol. 1997 Aug 11;138(3):671-80. doi: 10.1083/jcb.138.3.671. J Cell Biol. 1997. PMID: 9245794 Free PMC article.
-
A mechanism for beta-amyloid overproduction in Alzheimer's disease: precursor-independent generation of beta-amyloid via antisense RNA-primed mRNA synthesis.FEBS Lett. 1996 Jul 22;390(2):124-8. doi: 10.1016/0014-5793(96)00663-1. FEBS Lett. 1996. PMID: 8706841 Review.
-
Alzheimer's disease.Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Subcell Biochem. 2012. PMID: 23225010 Review.
Cited by
-
Transthyretin and the brain re-visited: is neuronal synthesis of transthyretin protective in Alzheimer's disease?Mol Neurodegener. 2011 Nov 23;6:79. doi: 10.1186/1750-1326-6-79. Mol Neurodegener. 2011. PMID: 22112803 Free PMC article. Review.
-
Sorting through the cell biology of Alzheimer's disease: intracellular pathways to pathogenesis.Neuron. 2006 Oct 5;52(1):15-31. doi: 10.1016/j.neuron.2006.09.001. Neuron. 2006. PMID: 17015224 Free PMC article. Review.
-
Molecular rationale for the pharmacological treatment of Alzheimer's disease.Drugs Aging. 2005;22 Suppl 1:27-37. doi: 10.2165/00002512-200522001-00003. Drugs Aging. 2005. PMID: 16506440 Review.
-
The Role of microRNAs in Alzheimer's Disease and Their Therapeutic Potentials.Genes (Basel). 2018 Mar 21;9(4):174. doi: 10.3390/genes9040174. Genes (Basel). 2018. PMID: 29561798 Free PMC article. Review.
-
The amyloid beta ion channel hypothesis of Alzheimer's disease.Neuropsychiatr Dis Treat. 2007;3(5):597-612. Neuropsychiatr Dis Treat. 2007. PMID: 19300589 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical